Workflow
HealthStream(HSTM) - 2025 Q1 - Quarterly Results
HSTMHealthStream(HSTM)2025-05-05 20:55

Financial Performance - Revenues for Q1 2025 increased by 0.7million,or1.00.7 million, or 1.0%, to 73.5 million compared to Q1 2024's 72.8million[4]−OperatingincomeforQ12025was72.8 million[4] - Operating income for Q1 2025 was 4.4 million, down 23.1% from 5.7millioninQ12024[5]−NetincomeforQ12025was5.7 million in Q1 2024[5] - Net income for Q1 2025 was 4.3 million, a decrease of 17.1% from 5.2millioninQ12024,withdilutedEPSat5.2 million in Q1 2024, with diluted EPS at 0.14, down from 0.17[6]−AdjustedEBITDAforQ12025was0.17[6] - Adjusted EBITDA for Q1 2025 was 16.2 million, down 5.0% from 17.1millioninQ12024[6]−NetincomeforQ12025was17.1 million in Q1 2024[6] - Net income for Q1 2025 was 4,332,000, a decrease of 17.1% from 5,227,000inQ12024[27]−AdjustedEBITDAforQ12025was5,227,000 in Q1 2024[27] - Adjusted EBITDA for Q1 2025 was 16,201,000, down 5.0% from 17,059,000inQ12024[29]CashandCashEquivalents−AsofMarch31,2025,thecompanyhadcash,cashequivalents,andmarketablesecuritiestotaling17,059,000 in Q1 2024[29] Cash and Cash Equivalents - As of March 31, 2025, the company had cash, cash equivalents, and marketable securities totaling 113.3 million[9] - Cash and cash equivalents at the end of Q1 2025 were 77,289,000,upfrom77,289,000, up from 52,407,000 at the end of Q1 2024, representing a 47.4% increase[27] Guidance and Projections - The updated revenue guidance for full year 2025 is between 297.5millionand297.5 million and 303.5 million, down from the previous range of 302.0to302.0 to 307.0 million[13] - The updated net income guidance for 2025 is between 18.6millionand18.6 million and 21.0 million, revised from 19.2to19.2 to 21.4 million[13] - The company projects net income for 2025 to be between 18,600,000and18,600,000 and 21,000,000[31] - Adjusted EBITDA guidance for 2025 is set between 68,500,000and68,500,000 and 72,500,000[31] Capital Expenditures and Investments - Capital expenditures for Q1 2025 were 7.9million,withfullyearguidancesetbetween7.9 million, with full year guidance set between 31.0 million and 34.0million[9][13]−Thecompanyreportedanetcashusedininvestingactivitiesof34.0 million[9][13] - The company reported a net cash used in investing activities of 7,248,000 in Q1 2025, slightly higher than 7,120,000inQ12024[27]OtherFinancialMetrics−Stock−basedcompensationexpenseforQ12025was7,120,000 in Q1 2024[27] Other Financial Metrics - Stock-based compensation expense for Q1 2025 was 1,104,000, slightly up from 1,060,000inQ12024[29]−DepreciationandamortizationforQ12025was1,060,000 in Q1 2024[29] - Depreciation and amortization for Q1 2025 was 10,755,000, compared to 10,336,000inQ12024,indicatinga4.010,336,000 in Q1 2024, indicating a 4.0% increase[29] - Net cash provided by operating activities increased to 27,074,000 in Q1 2025, compared to 20,938,000inQ12024,reflectingagrowthof29.420,938,000 in Q1 2024, reflecting a growth of 29.4%[27] Customer Contracts - The company signed one of the largest customer contracts in its history during Q1 2025[16] Exchange Rate Effects - The effect of exchange rate changes on cash and cash equivalents resulted in a gain of 7,000 in Q1 2025, compared to a loss of 40,000inQ12024[27]Dividends−Thecompanydeclaredaquarterlycashdividendof40,000 in Q1 2024[27] Dividends - The company declared a quarterly cash dividend of 0.031 per share, payable on May 30, 2025[8]